There are 2789 resources available
376P - Nucleolin and its prognostic value in pediatric patients with intracranial ependymoma: A systematic review and meta-analysis
Presenter: Jeremiah Wijaya
Session: ePoster Display
308P - FDG-PET/CT versus CE-CT for response monitoring in metastatic breast cancer: A prospective comparative study
Presenter: Marianne Vogsen
Session: ePoster Display
309P - Antineoplastic (ANP) therapies (Tx) after alpelisib (ALP) or placebo (PBO) + fulvestrant (FUL) in patients (Pts) with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–), PIK3CA-mutated (Mut) advanced breast cancer (ABC): An analysis from SOLAR-1
Presenter: Fabrice André
Session: ePoster Display
294P - Cell-free DNA (cfDNA) workflow for the risk definition of dose-limiting and recurrent neutropenia in patients treated with first-line endocrine therapy (ET) and cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) for metastatic breast cancer (MBC)
Presenter: Lorenza Palmero
Session: ePoster Display
295P - Clinical characterization and outcome of a HER2-low metastatic breast cancer (mBC) cohort receiving first-line treatment (1L) with ET +/- CDK 4/6 inhibitor (CDKi)
Presenter: Lucia Bortot
Session: ePoster Display
296P - Recapitulation of organ-specific breast cancer metastasis using an engineered multi-tissue platform
Presenter: Alan Chramiec
Session: ePoster Display
381TiP - Vaccination with autologous dendritic cells loaded with autologous tumour homogenate in resected glioblastoma: A phase II study (CombiGVax)
Presenter: Laura Ridolfi
Session: ePoster Display
461P - Molecular tumor profiling and matched molecular targeted treatment in metastatic young-onset colorectal cancer (YOCR)
Presenter: Iosune Baraibar Argota
Session: ePoster Display
462P - Heterogeneity of mismatch repair status between primary tumors and matched metastases in metastatic colorectal cancer
Presenter: David Tougeron
Session: ePoster Display